Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-10

Clinical Trial Update: Preoperative Chemoradiotherapy Utilizing Intensity Modulated Radiation Therapy in Combination With Bevacizumab-FOLFOX [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating preoperative chemoradiotherapy with intensity-modulated radiation therapy in combination with Bevacizumab-FOLFOX for rectal cancer; the…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • 5-Fluorouracil (5-FU)
  • Bevacizumab (bevacizumab)
  • Leucovorin (folinic acid)
  • OXALIPLATIN (Oxaliplatin)

Snippet

Sponsor: National Taiwan University Hospital | Conditions: Rectal Cancer | Phase 1 | Status: COMPLETED